エクソスケルトン市場 – 2030年までの世界予測

本調査レポートは、エクソスケルトン（外骨格）市場をコンポーネント（ハードウェア、ソフトウェア）、タイプ（電動、受動、ハイブリッド）、部位（下肢、上肢、全身）、構造（リジッド、ソフト）、モビリティ（固定、モバイル）、垂直（医療、防衛、産業、建設、その他の垂直）、地域（北米、欧州、アジア太平洋、その他の地域）別に分類しています。レポートは、外骨格市場の成長に影響を与える推進要因、制約、課題、機会など、主要な要因に関する詳細な情報を網羅しています。主要業界プレーヤーの詳細な分析により、事業概要、ソリューション、サービス、主要戦略（契約、パートナーシップ、合意、新製品発売、合併・買収）、そして外骨格市場に関連する最近の動向に関する洞察を提供しています。本レポートは、外骨格市場エコシステムにおける新興企業の競合分析も網羅しています。

The exoskeleton market is estimated to be USD 0.56 billion in 2025 and is projected to reach USD 2.03 billion by 2030, registering a CAGR of 29.4% during the forecast period.

エクソスケルトン（外骨格）市場は2025年には5億6,000万米ドルに達すると推定され、2030年までに20億3,000万米ドルに達すると予測されており、予測期間中に29.4%のCAGRを記録します。

Exoskeletons are important for improving mobility for people with physical impairment and reducing physical strain for industrial workers, leading to the integration of exoskeletons in healthcare and manufacturing. As the elderly population increases and patients at home for rehabilitation become more prevalent, the need for exoskeletons will only rise. As more technologies become available (AI, sensors, lightweight materials), exoskeleton products will function better, cheaper, and be more available. The process of product development and the growth of the exoskeleton market internationally will only be improved by continued investments by both the public and private sectors.

エクソスケルトンは、身体に障がいのある人々の移動能力の向上や産業従事者の身体的負担軽減に重要であり、医療や製造業への統合が進んでいます。高齢者人口の増加や在宅リハビリテーション患者の増加に伴い、外骨格のニーズはますます高まっていくでしょう。AI、センサー、軽量素材といった技術の進歩に伴い、外骨格製品はより高性能で、より安価になり、より入手しやすくなります。製品開発プロセスの改善と国際的な外骨格市場の成長は、官民双方による継続的な投資によってのみ実現できるでしょう。

“Powered exoskeleton segment to register the highest CAGR during the forecast period.”

The market for powered exoskeletons is experiencing accelerated growth, fueled by significant funding activities that underscore rising investor confidence and commercialization potential. For instance, in December 2023, German Bionic, a developer of electrically powered exoskeletons, secured more than USD 16.3 million in an expanded Series A funding round. This funding is aimed at strengthening the company’s collaboration with its industrialization partner, Mubea, to scale production and improve deployment capabilities. In the same month, Verve Motion, a Cambridge-based startup specializing in robotic exosuits designed to enhance the physical capabilities of workers in demanding roles, successfully raised USD 20 million in a Series B funding round. These developments reflect a broader trend of strategic investments in powered exoskeleton technologies, positioning them as viable solutions for industrial automation, injury prevention, and workforce augmentation across various sectors.

“Industrial vertical to register the second-highest CAGR during the forecast period.”

The industrial sector is rapidly emerging as a significant adopter of exoskeleton technology, driven by the need to improve worker safety, reduce fatigue, and increase productivity in labor-intensive environments. Exoskeletons are particularly useful in industries such as manufacturing, warehousing, logistics, and assembly lines, where workers often perform repetitive lifting, bending, and overhead tasks. By supporting the lower back, shoulders, and legs, these wearable devices help reduce the risk of musculoskeletal injuries, one of the most common causes of lost workdays and rising occupational health costs.

“Germany to dominate European exoskeleton market.”

Germany represents one of the most advanced and mature markets for exoskeleton technology in Europe, driven by strong industrial demand, innovation in healthcare, and significant private investments. The country’s robust manufacturing and logistics sectors are actively adopting exoskeletons to improve workforce efficiency and reduce musculoskeletal injuries. German Bionic, a leading domestic developer, exemplifies this trend. In December 2023, the company raised over USD 16.3 million in an expanded Series A funding round to advance its product portfolio. Its exoskeletons, Apogee and Apogee+, are used in logistics, retail, and healthcare settings to assist with lifting, walking, and posture correction. These connected wearables are helping redefine workplace ergonomics across Germany’s key industries.

• By Company Type: Tier 1 – 25%, Tier 2 – 40%, and Tier 3 – 35%
• By Designation: C-level Executives – 30%, Directors – 28%, and Others – 42%
• By Region: North America– 43%, Europe – 15%, Asia Pacific– 37%, and RoW- 05%

Ekso Bionics (US), Ottobock (Germany), DIH Medical (Switzerland), Comau (Italy), Myomo Inc. (US), CYBERDYNE Inc. (Japan), Lifeward Ltd. (Israel), Hyundai Motor Group Robotics LAB. (South Korea), B-Temia (Canada), Rex Bionics Ltd. (New Zealand), ABLE Human Motion (Spain), Laevo Exoskeletons (Netherlands), German Bionic Systems GmbH (Germany), and Levitate Technologies, Inc. (US) are some of the key players in the exoskeleton market.

The study includes an in-depth competitive analysis of these key players in the exoskeleton market, with their company profiles, recent developments, and key market strategies.

Research Coverage

This research report categorizes the exoskeleton market by component (hardware, software), type (powered, passive, hybrid), body part (lower extremities, upper extremities, full body), structure (rigid, soft), mobility (stationary, mobile), vertical (healthcare, defense, industrial, construction, other verticals), and region (North America, Europe, Asia Pacific, and RoW). The report’s scope covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the exoskeleton market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies (contracts, partnerships, agreements, new product launches, mergers & acquisitions); and recent developments associated with the exoskeleton market. This report covers the competitive analysis of upcoming startups in the exoskeleton market ecosystem.

Reasons to Buy This Report

The report will help market leaders and new entrants with information on the closest approximations of the revenue numbers for the overall exoskeleton market and its subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

• Analysis of key drivers (Rising demand for robotic rehabilitation solutions from healthcare sector, Increased adoption in industrial and manufacturing sectors, Increased FDA approvals for medical exoskeletons), restraints (High cost of ownership), opportunities (Integration of exoskeletons with AI and IoT technologies, Increasing adoption of exoskeletons in military and defense sector), and challenges (Comfort and movement interference for workers, Power supply limitations and operational downtime) influencing the growth of the exoskeleton market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the exoskeleton market
• Market Development: Comprehensive information about lucrative markets – the report analyses the exoskeleton market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the exoskeleton market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Ekso Bionics (US), Ottobock (Germany), DIH Medical (Switzerland), Comau (Italy), Myomo Inc. (US), CYBERDYNE Inc. (Japan), Lifeward Ltd. (Israel), Hyundai Motor Group Robotics LAB. (South Korea), B-Temia (Canada), Rex Bionics Ltd. (New Zealand), ABLE Human Motion (Spain), Laevo Exoskeletons (Netherlands), German Bionic Systems GmbH (Germany), Levitate Technologies, Inc. (US), among others in the exoskeleton market.

Table of Contents

1               INTRODUCTION              24

1.1           STUDY OBJECTIVES       24

1.2           MARKET DEFINITION   24

1.3           STUDY SCOPE   25

1.3.1        MARKET SEGMENTATION AND REGIONAL SCOPE                 25

1.3.2        YEARS CONSIDERED      25

1.3.3        INCLUSIONS AND EXCLUSIONS 26

1.4           CURRENCY CONSIDERED            26

1.5           UNITS CONSIDERED      26

1.6           LIMITATIONS    26

1.7           STAKEHOLDERS               27

1.8           SUMMARY OF CHANGES               27

2               RESEARCH METHODOLOGY       29

2.1           RESEARCH DATA              29

2.1.1        SECONDARY DATA          30

2.1.1.1    List of major secondary sources         30

2.1.1.2    Key data from secondary sources       30

2.1.2        PRIMARY DATA 31

2.1.2.1    Intended participants and key opinion leaders in primary interviews               31

2.1.2.2    List of major participants in primary interviews              31

2.1.2.3    Key data from primary sources           32

2.1.2.4    Breakdown of primary interviews      32

2.1.3        SECONDARY AND PRIMARY RESEARCH 33

2.1.3.1    Key industry insights           34

2.2           MARKET SIZE ESTIMATION         34

2.2.1        BOTTOM-UP APPROACH              36

2.2.1.1    Approach to arrive at market size using bottom-up analysis (demand side)       36

2.2.2        TOP-DOWN APPROACH                37

2.2.2.1    Approach to arrive at market size using top-down analysis (supply side)        37

2.3           MARKET BREAKDOWN AND DATA TRIANGULATION                 38

2.4           RESEARCH ASSUMPTIONS           39

2.5           RESEARCH LIMITATIONS             39

2.6           RISK ASSESSMENT           39

3               EXECUTIVE SUMMARY  40

4               PREMIUM INSIGHTS       44

4.1           ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN EXOSKELETON MARKET               44

4.2           EXOSKELETON MARKET IN NORTH AMERICA, BY COUNTRY AND VERTICAL           45

4.3           EXOSKELETON MARKET IN ASIA PACIFIC, BY VERTICAL                 45

4.4           EXOSKELETON MARKET, BY COUNTRY 46

5               MARKET OVERVIEW       47

5.1           INTRODUCTION              47

5.2           MARKET DYNAMICS       47

5.2.1        DRIVERS               48

5.2.1.1    Rising demand for robotic rehabilitation solutions from healthcare sector  48

5.2.1.2    Increased adoption in industrial and manufacturing sectors                 48

5.2.1.3    Increased FDA approvals for medical exoskeletons        49

5.2.2        RESTRAINTS      49

5.2.2.1    High cost of ownership        50

5.2.3        OPPORTUNITIES              50

5.2.3.1    Integration of exoskeletons with AI and IoT technologies                 50

5.2.3.2    Increasing adoption of exoskeletons in military and defense sectors    51

5.2.4        CHALLENGES    51

5.2.4.1    Comfort and movement interference for workers           51

5.2.4.2    Power supply limitations and operational downtime      52

5.3           VALUE CHAIN ANALYSIS               52

5.4           ECOSYSTEM ANALYSIS  54

5.5           TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS            55

5.6           PRICING ANALYSIS          56

5.6.1        PRICING RANGE OF EXOSKELETON OFFERED BY KEY PLAYERS, BY TYPE, 2024                 57

5.6.2        AVERAGE SELLING PRICE TREND OF EXOSKELETON, BY TYPE, 2022–2024                 58

5.6.3        AVERAGE SELLING PRICE TREND OF POWERED EXOSKELETON, BY REGION, 2022–2024   59

5.6.4        AVERAGE SELLING PRICE TREND OF PASSIVE EXOSKELETON, BY REGION, 2022–2024   60

5.7           TECHNOLOGY ANALYSIS             61

5.7.1        KEY TECHNOLOGIES     61

5.7.1.1    Actuators and motors           61

5.7.1.2    Sensors and feedback systems            61

5.7.2        COMPLEMENTARY TECHNOLOGIES       62

5.7.2.1    IoT connectivity    62

5.7.2.2    AI and ML              62

5.7.3        ADJACENT TECHNOLOGIES       62

5.7.3.1    Artificial muscles  62

5.7.3.2    Physical therapy equipment                62

5.8           PORTER’S FIVE FORCES ANALYSIS            63

5.8.1        INTENSITY OF COMPETITIVE RIVALRY 64

5.8.2        BARGAINING POWER OF SUPPLIERS       64

5.8.3        BARGAINING POWER OF BUYERS             64

5.8.4        THREAT OF SUBSTITUTES          64

5.8.5        THREAT OF NEW ENTRANTS      64

5.9           KEY STAKEHOLDERS AND BUYING CRITERIA     65

5.9.1        KEY STAKEHOLDERS IN BUYING PROCESS           65

5.9.2        BUYING CRITERIA           66

5.10         CASE STUDY ANALYSIS 67

5.10.1      ENHANCING WORKER ERGONOMICS AND PRODUCTIVITY AT JOHN DEERE WITH COMAU’S MATE-XT WEARABLE EXOSKELETON         67

5.10.2      ENHANCING LOGISTICS OPERATIONS AND WORKER WELL-BEING AT FIEGE GROUP WITH GERMAN BIONIC AI-POWERED EXOSKELETON TECHNOLOGY            67

5.10.3      ENHANCING WORKER SAFETY AND PRODUCTIVITY IN TUNNEL CONSTRUCTION AT GRANITE CONSTRUCTION WITH LEVITATE TECHNOLOGIES EXOSKELETONS      68

5.10.4      REDUCING PHYSICAL STRAIN IN TRUCK MAINTENANCE AT MAN TRUCK & BUS WITH HELP OF SUITX TECHNOLOGY BY OTTOBOCK  68

5.10.5      FORD MOTOR COMPANY ENHANCES WORKER SAFETY AND REDUCES INJURIES WITH EKSO BIONICS EKSOVEST                 68

5.11         INVESTMENT AND FUNDING SCENARIO               69

5.12         TRADE ANALYSIS, 2020–2024        69

5.12.1      IMPORT SCENARIO (HS CODE 9021)        69

5.12.2      EXPORT SCENARIO (HS CODE 9021)        70

5.13         PATENT ANALYSIS          72

5.14         KEY CONFERENCES AND EVENTS, 2025–2026        75

5.15         TARIFF AND REGULATORY LANDSCAPE               76

5.15.1      TARIFF ANALYSIS, 2024  76

5.15.2      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             77

5.15.3      STANDARDS      79

5.16         IMPACT OF AI ON EXOSKELETON MARKET         79

5.16.1      INTRODUCTION              79

5.16.2      AI-SPECIFIC USE CASES 80

5.17         2025 US TARIFF IMPACT ON EXOSKELETON MARKET                 81

5.17.1      INTRODUCTION              81

5.17.2      KEY TARIFF RATES          81

5.17.3      PRICE IMPACT ANALYSIS             82

5.17.4      KEY IMPACTS ON VARIOUS COUNTRIES/REGIONS                 83

5.17.4.1  US           83

5.17.4.2  Europe   84

5.17.4.3  Asia Pacific            84

5.17.5      END-USE INDUSTRY IMPACT     85

6               EXOSKELETON MARKET, BY MATERIAL                 87

6.1           INTRODUCTION              87

6.2           CARBON FIBER 87

6.2.1        GROWING EMPHASIS ON LIGHTWEIGHT MATERIALS IN WEARABLE ROBOTICS TO DRIVE MARKET           87

6.3           METAL 88

6.3.1        HIGH STRUCTURAL STRENGTH AND LOAD-BEARING CAPACITY TO DRIVE DEMAND 88

6.4           STEEL ALLOYS  88

6.4.1        SUPERIOR DURABILITY IN HARSH WORK ENVIRONMENTS TO DRIVE MARKET      88

6.5           ALUMINUM        89

6.5.1        CORROSION RESISTANCE AND LIGHTWEIGHT DESIGN TO FUEL SEGMENT GROWTH    89

7               EXOSKELETON MARKET, BY STRUCTURE             90

7.1           INTRODUCTION              90

7.2           RIGID EXOSKELETONS 90

7.2.1        RISING DEMAND FOR REHABILITATION THERAPIES TO DRIVE MARKET 90

7.3           SOFT EXOSKELETONS   90

7.3.1        INCREASING STARTUP FUNDING AND EXPANDING USE IN PERSONAL STRUCTURE TO DRIVE MARKET  90

8               EXOSKELETON MARKET, BY MOBILITY 92

8.1           INTRODUCTION              93

8.2           STATIONARY     94

8.2.1        RISING DEMAND FOR REHABILITATION THERAPIES TO DRIVE MARKET 94

8.3           MOBILE                95

8.3.1        RISING STARTUP FUNDING AND EXPANDING USE IN PERSONAL MOBILITY TO DRIVE MARKET            95

9               EXOSKELETON MARKET, BY BODY PART              96

9.1           INTRODUCTION              97

9.2           LOWER EXTREMITIES    98

9.2.1        RISING PREVALENCE OF SPINAL CORD INJURIES TO BOOST MARKET DEMAND           98

9.3           UPPER EXTREMITIES     99

9.3.1        ADVANCEMENTS IN PASSIVE AND LIGHTWEIGHT EXOSKELETONS TO DRIVE MARKET       99

9.4           FULL BODY        100

9.4.1        ADOPTION IN COMPLEX REHABILITATION PROGRAMS AND RISING USE IN HEAVY INDUSTRIAL APPLICATIONS TO FUEL DEMAND 100

10            EXOSKELETON MARKET, BY COMPONENT          101

10.1         INTRODUCTION              102

10.2         SENSORS              103

10.2.1      INTEGRATION OF AI AND ML TO BOOST DEMAND                 103

10.2.2      GYROSCOPES    104

10.2.3      ACCELEROMETERS         104

10.2.4      TILT SENSORS  104

10.2.5      FORCE/TORQUE SENSORS          105

10.2.6      POSITION SENSORS        105

10.2.7      ELECTROMYOGRAPHY SENSORS              105

10.3         ACTUATORS      105

10.3.1      COMPATIBILITY WITH ADVANCED CONTROLLERS AND SENSORS FOR REAL-TIME MOTION COORDINATION TO DRIVE MARKET               105

10.4         POWER SOURCES             106

10.4.1      ADVANCEMENTS IN BATTERY TECHNOLOGIES TO BOOST MARKET               106

10.5         CONTROL SYSTEMS       106

10.5.1      ADVANCEMENTS IN ML AND REAL-TIME DATA PROCESSING TO DRIVE MARKET              106

10.6         OTHER COMPONENTS  107

11            EXOSKELETON MARKET, BY TYPE           108

11.1         INTRODUCTION              109

11.2         POWERED EXOSKELETON           110

11.2.1      RISING ADOPTION OF ROBOTIC ASSISTANCE IN REHABILITATION AND MOBILITY SUPPORT FOR PATIENTS TO FUEL MARKET GROWTH               110

11.2.2      POWERED EXOSKELETONS, BY TECHNOLOGY  112

11.2.2.1  Advancements in battery technology and energy-efficient actuators to fuel market growth          112

11.2.2.2  Electric   113

11.2.2.3  Pneumatic              114

11.2.2.4  Hydraulic               114

11.3         PASSIVE EXOSKELETON                114

11.3.1      INCREASING FOCUS ON WORKPLACE ERGONOMICS AND INJURY PREVENTION TO FUEL ADOPTION               114

12            EXOSKELETON MARKET, BY VERTICAL 117

12.1         INTRODUCTION              118

12.2         HEALTHCARE    119

12.2.1      RISING FDA CLEARANCE AND STARTUP FUNDING TO FUEL GROWTH OF MEDICAL EXOSKELETONS SEGMENT                 119

12.2.2      REHABILITATION            124

12.2.3      DISABILITY ASSISTANCE              124

12.2.4      ELDERLY CARE 124

12.3         DEFENSE             125

12.3.1      INCREASING DEMAND FOR ENHANCED SOLDIER PERFORMANCE AND OPERATIONAL EFFICIENCY TO COMPLEMENT MARKET GROWTH           125

12.3.2      ENHANCED MOBILITY  129

12.3.3      INJURY PREVENTION     129

12.3.4      STEALTH AND TACTICAL OPERATIONS                130

12.4         INDUSTRIAL      130

12.4.1      INCREASED FOCUS ON WORKPLACE SAFETY AND COMPLIANCE TO DRIVE MARKET            130

12.4.2      HEAVY LIFTING                134

12.4.3      REPETITIVE TASK ASSISTANCE 134

12.4.4      POSTURAL SUPPORT     135

12.4.5      LOGISTICS          135

12.4.6      MATERIAL HANDLING  135

12.5         CONSTRUCTION              136

12.5.1      INCREASING FOCUS ON WORKER HEALTH TO FUEL ADOPTION OF EXOSKELETONS                136

12.5.2      LIFTING ASSISTANCE    140

12.5.3      ENHANCED PRODUCTIVITY AND EFFICIENCY  140

12.6         OTHER VERTICALS         141

13            EXOSKELETON MARKET, BY REGION     146

13.1         INTRODUCTION              147

13.2         NORTH AMERICA             148

13.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 149

13.2.2      US           150

13.2.2.1  Growing military focus on injury prevention and surge in startup funding to drive market       150

13.2.3      CANADA               151

13.2.3.1  Government contracts supporting defense applications to boost market    151

13.2.4      MEXICO                152

13.2.4.1  Strategic investments in hospital infrastructure to foster revenue growth    152

13.3         EUROPE               153

13.3.1      MACROECONOMIC OUTLOOK FOR EUROPE      154

13.3.2      UK          155

13.3.2.1  Government support through defense innovation program to propel market        155

13.3.3      GERMANY           156

13.3.3.1  Presence of leading exoskeleton manufacturers and startups to complement revenue growth               156

13.3.4      FRANCE                157

13.3.4.1  Strong public and private investment in MedTech to boost market    157

13.3.5      ITALY    159

13.3.5.1  Strong collaboration between research institutes and industry to drive market          159

13.3.6      POLAND               160

13.3.6.1  Strategic partnerships with global exoskeleton providers to drive market    160

13.3.7      NORDICS             161

13.3.7.1  Academic and institutional R&D in robotics to drive market                 161

13.3.8      REST OF EUROPE             162

13.4         ASIA PACIFIC     163

13.4.1      MACRO ECONOMIC OUTLOOK FOR ASIA PACIFIC                 165

13.4.2      CHINA  166

13.4.2.1  Military investment in wearable robotics for logistics and mobility to boost market     166

13.4.3      JAPAN   167

13.4.3.1  Rapidly aging population and government support to create lucrative market growth opportunities              167

13.4.4      SOUTH KOREA  168

13.4.4.1  Advancements in lightweight, AI-integrated wearable robotics systems to drive market       168

13.4.5      INDIA    170

13.4.5.1  Military adoption for enhanced soldier endurance and injury prevention to boost market 170

13.4.6      AUSTRALIA         171

13.4.6.1  High healthcare spending to encourage adoption of advanced assistive technologies and boost demand          171

13.4.7      INDONESIA        172

13.4.7.1  High paraplegic population demanding affordable mobility rehabilitation solutions to drive market             172

13.4.8      MALAYSIA           173

13.4.8.1  Rising demand for rehabilitation devices that support patient mobility recovery to create growth opportunities            173

13.4.9      THAILAND          174

13.4.9.1  Government-backed research funding to boost exoskeleton technology development      174

13.4.10   VIETNAM             175

13.4.10.1                 Increased research initiatives by domestic academic and medical institutions to drive market  175

13.4.11   REST OF ASIA PACIFIC   176

13.5         REST OF THE WORLD    177

13.5.1      MACROECONOMIC OUTLOOK FOR ROW              177

13.5.2      MIDDLE EAST   178

13.5.2.1  Bahrain  180

13.5.2.1.1                Growing adoption of smart transportation and home automation to drive demand               180

13.5.2.2  Kuwait    180

13.5.2.2.1                Focus on improving healthcare accessibility and patient outcomes to fuel market      180

13.5.2.3  Oman     180

13.5.2.3.1                Rising prevalence of neurological and musculoskeletal disorders to drive market    180

13.5.2.4  Qatar      181

13.5.2.4.1                Strategic focus on defense modernization and soldier performance to increase market demand          181

13.5.2.5  Saudi Arabia          181

13.5.2.5.1                Vision 2030 focus on healthcare innovation and technology adoption to fuel market   181

13.5.2.6  UAE        182

13.5.2.6.1                Investment in R&D of intelligent robotic systems to drive market          182

13.5.2.7  Rest of the Middle East       182

13.5.3      SOUTH AMERICA             182

13.5.3.1  Partnerships with global exoskeleton technology providers and manufacturers to support market       182

13.5.4      AFRICA 183

13.5.5      SOUTH AFRICA 185

13.5.5.1  Focus on improving worker safety in high-risk mining operations to drive market      185

13.5.6      OTHER AFRICAN COUNTRIES    185

14            COMPETITIVE LANDSCAPE         186

14.1         OVERVIEW          186

14.2         KEY PLAYER STRATEGIES/RIGHT TO WIN, JANUARY 2022–FEBRUARY 2025      186

14.3         REVENUE ANALYSIS, 2019–2023  188

14.4         MARKET SHARE ANALYSIS, 2024                 189

14.5         COMPANY VALUATION AND FINANCIAL METRICS, 2024                 191

14.6         BRAND/PRODUCT COMPARISON             192

14.7         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 193

14.7.1      STARS   193

14.7.2      EMERGING LEADERS     193

14.7.3      PERVASIVE PLAYERS      193

14.7.4      PARTICIPANTS 193

14.7.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         195

14.7.5.1  Company footprint               195

14.7.5.2  Region footprint   196

14.7.5.3  Vertical footprint  197

14.7.5.4  Type footprint       198

14.7.5.5  Body part footprint               199

14.8         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        200

14.8.1      PROGRESSIVE COMPANIES         200

14.8.2      RESPONSIVE COMPANIES            200

14.8.3      DYNAMIC COMPANIES  200

14.8.4      STARTING BLOCKS         200

14.8.5      COMPETITIVE BENCHMARKING: KEY STARTUPS/SMES, 2024        202

14.8.5.1  Detailed list of startups/SMEs           202

14.8.5.2  Competitive benchmarking of key startups/SMEs          203

14.9         COMPETITIVE SCENARIO             204

14.9.1      PRODUCT LAUNCHES   204

14.9.2      DEALS  205

14.9.3      EXPANSIONS     206

14.9.4      OTHER DEVELOPMENTS              207

15            COMPANY PROFILES      208

15.1         KEY PLAYERS     208

15.1.1      EKSO BIONICS  208

15.1.1.1  Business overview 208

15.1.1.2  Products/Solutions/Services offered 209

15.1.1.3  Recent developments           210

15.1.1.3.1                Product launches  210

15.1.1.3.2                Deals      210

15.1.1.3.3                Other developments             211

15.1.1.4  MnM view              211

15.1.1.4.1                Key strengths/Right to win 211

15.1.1.4.2                Strategic choices   211

15.1.1.4.3                Weaknesses and competitive threats 211

15.1.2      OTTOBOCK        212

15.1.2.1  Business overview 212

15.1.2.2  Products/Solutions/Services offered 212

15.1.2.3  Recent developments           213

15.1.2.3.1                Product launches  213

15.1.2.4  MnM view              213

15.1.2.4.1                Key strengths/Right to win 213

15.1.2.4.2                Strategic choices   213

15.1.2.4.3                Weaknesses and competitive threats 213

15.1.3      DIH MEDICAL   214

15.1.3.1  Business overview 214

15.1.3.2  Products/Solutions/Services offered 215

15.1.3.3  Recent developments           216

15.1.3.3.1                Deals      216

15.1.3.4  MnM view              216

15.1.3.4.1                Key strengths/Right to win 216

15.1.3.4.2                Strategic choices   217

15.1.3.4.3                Weaknesses and competitive threats 217

15.1.4      COMAU                 218

15.1.4.1  Business overview 218

15.1.4.2  Products/Solutions/Services offered 218

15.1.4.3  Recent developments           219

15.1.4.3.1                Product launches  219

15.1.4.4  MnM view              219

15.1.4.4.1                Key strengths/Right to win 219

15.1.4.4.2                Strategic choices   219

15.1.4.4.3                Weaknesses and competitive threats 220

15.1.5      MYOMO INC.     221

15.1.5.1  Business overview 221

15.1.5.2  Products/Solutions/Services offered 222

15.1.5.3  Recent developments           222

15.1.5.3.1                Product launches  222

15.1.5.3.2                Other developments             223

15.1.5.4  MnM view              223

15.1.5.4.1                Key strengths/Right to win 223

15.1.5.4.2                Strategic choices   223

15.1.5.4.3                Weaknesses and competitive threats 223

15.1.6      CYBERDYNE INC.             224

15.1.6.1  Business overview 224

15.1.6.2  Products/Solutions/Services offered 225

15.1.6.3  Recent developments           226

15.1.6.3.1                Expansions             226

15.1.7      LIFEWARD LTD.                227

15.1.7.1  Business overview 227

15.1.7.2  Products/Solutions/Services offered 228

15.1.7.3  Recent developments           229

15.1.7.3.1                Deals      229

15.1.8      HYUNDAI MOTOR GROUP ROBOTICS LAB.          230

15.1.8.1  Business overview 230

15.1.8.2  Products/Solutions/Services offered 230

15.1.8.3  Recent developments           231

15.1.8.3.1                Product launches  231

15.1.8.3.2                Deals      231

15.1.9      B-TEMIA               232

15.1.9.1  Business overview 232

15.1.9.2  Products/Solutions/Services offered 232

15.1.10   REX BIONICS LTD.           233

15.1.10.1                 Business overview 233

15.1.10.2                 Products/Solutions/Services offered 233

15.2         OTHER PLAYERS              234

15.2.1      ABLE HUMAN MOTION 234

15.2.2      LAEVO EXOSKELETONS                235

15.2.3      GERMAN BIONIC SYSTEMS GMBH            236

15.2.4      LEVITATE TECHNOLOGIES, INC.              237

15.2.5      FOURIER              238

15.2.6      TREXO ROBOTICS           239

15.2.7      WANDERCRAFT                240

15.2.8      AGADE 241

15.2.9      EUROPE TECHNOLOGIES             242

15.2.10   GOGOA.EU         243

15.2.11   ARCHELIS INC.  244

15.2.12   P&S MECHANICS CO., LTD.          245

15.2.13   RB3D     246

15.2.14   JAPET MEDICAL DEVICES            247

15.2.15   PROTESO S.R.L. 248

16            APPENDIX           249

16.1         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                251

16.2         CUSTOMIZATION OPTIONS        253

16.3         RELATED REPORTS         253

16.4         AUTHOR DETAILS           254

LIST OF TABLES

TABLE 1                EXOSKELETON MARKET: ROLE OF COMPANIES IN ECOSYSTEM 55

TABLE 2                PRICING RANGE OF EXOSKELETON OFFERED BY KEY PLAYERS,

BY TYPE (USD), 2024       57

TABLE 3                AVERAGE SELLING PRICE TREND OF EXOSKELETON, BY TYPE, 2022–2024 (USD)           58

TABLE 4                AVERAGE SELLING PRICE TREND OF POWERED EXOSKELETON,

BY REGION (USD), 2022–2024       59

TABLE 5                AVERAGE SELLING PRICE TREND OF PASSIVE EXOSKELETON,

BY REGION (USD), 2022–2024       60

TABLE 6                EXOSKELETON MARKET: PORTER’S FIVE FORCES ANALYSIS           63

TABLE 7                INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR EXOSKELETONS FOR TOP THREE VERTICALS                 65

TABLE 8                KEY BUYING CRITERIA FOR EXOSKELETONS FOR TOP THREE VERTICALS       66

TABLE 9                IMPORT SCENARIO FOR HS CODE 9021-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION)            70

TABLE 10              EXPORT SCENARIO FOR HS CODE 9021-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION)            71

TABLE 11              EXOSKELETON MARKET: LIST OF MAJOR PATENTS, 2022–2024        72

TABLE 12              EXOSKELETON MARKET: KEY CONFERENCES AND EVENTS, 2025–2026                 75

TABLE 13              MFN TARIFF FOR HS CODE 9021-COMPLIANT PRODUCTS EXPORTED

BY US, 2024          76

TABLE 14              NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 77

TABLE 15              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  77

TABLE 16              ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  78

TABLE 17              ROW: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS           78

TABLE 18              US-ADJUSTED RECIPROCAL TARIFF RATES, 2024 (USD BILLION) 81

TABLE 19              EXPECTED CHANGE IN PRICES AND IMPACT ON END-USE MARKETS DUE TO TARIFF IMPACT      82

TABLE 20              EXOSKELETON MARKET, BY MOBILITY, 2021–2024 (USD MILLION)       93

TABLE 21              EXOSKELETON MARKET, BY MOBILITY, 2025–2030 (USD MILLION)       93

TABLE 22              STATIONARY: EXOSKELETON MARKET, BY TYPE, 2021–2024 (USD MILLION)                94

TABLE 23              STATIONARY: EXOSKELETON MARKET, BY TYPE, 2025–2030 (USD MILLION)                94

TABLE 24              MOBILE: EXOSKELETON MARKET, BY TYPE, 2021–2024 (USD MILLION)            95

TABLE 25              MOBILE: EXOSKELETON MARKET, BY TYPE, 2025–2030 (USD MILLION)            95

TABLE 26              EXOSKELETON MARKET, BY BODY PART, 2021–2024 (USD MILLION)       97

TABLE 27              EXOSKELETON MARKET, BY BODY PART, 2025–2030 (USD MILLION)       97

TABLE 28              LOWER EXTREMITIES: EXOSKELETON MARKET, BY TYPE,

2021–2024 (USD MILLION)            98

TABLE 29              LOWER EXTREMITIES: EXOSKELETON MARKET, BY TYPE,

2025–2030 (USD MILLION)            99

TABLE 30              UPPER EXTREMITIES: EXOSKELETON MARKET, BY TYPE,

2021–2024 (USD MILLION)            99

TABLE 31              UPPER EXTREMITIES: EXOSKELETON MARKET, BY TYPE,

2025–2030 (USD MILLION)            100

TABLE 32              FULL BODY: EXOSKELETON MARKET, BY TYPE, 2021–2024 (USD MILLION)            100

TABLE 33              FULL BODY: EXOSKELETON MARKET, BY TYPE, 2025–2030 (USD MILLION)            100

TABLE 34              EXOSKELETON MARKET, BY COMPONENT, 2021–2024 (USD MILLION)            102

TABLE 35              EXOSKELETON MARKET, BY COMPONENT, 2025–2030 (USD MILLION)            103

TABLE 36              EXOSKELETON MARKET, BY TYPE, 2021–2024 (USD MILLION) 109

TABLE 37              EXOSKELETON MARKET, BY TYPE, 2025–2030 (USD MILLION) 109

TABLE 38              EXOSKELETON MARKET, BY TYPE, 2021–2024 (THOUSAND UNITS)      110

TABLE 39              EXOSKELETON MARKET, BY TYPE, 2025–2030 (THOUSAND UNITS)      110

TABLE 40              POWERED: EXOSKELETON MARKET, BY BODY PART, 2021–2024 (USD MILLION)               111

TABLE 41              POWERED: EXOSKELETON MARKET, BY BODY PART, 2025–2030 (USD MILLION)               111

TABLE 42              POWERED: EXOSKELETON MARKET, BY MOBILITY, 2021–2024 (USD MILLION)     111

TABLE 43              POWERED: EXOSKELETON MARKET, BY MOBILITY, 2025–2030 (USD MILLION)     111

TABLE 44              POWERED: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION)     112

TABLE 45              POWERED: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION)     112

TABLE 46              POWERED: EXOSKELETON MARKET, BY TECHNOLOGY, 2021–2024 (USD MILLION)            113

TABLE 47              POWERED: EXOSKELETON MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION)            113

TABLE 48              PASSIVE: EXOSKELETON MARKET, BY BODY PART, 2021–2024 (USD MILLION)               115

TABLE 49              PASSIVE: EXOSKELETON MARKET, BY BODY PART, 2025–2030 (USD MILLION)               115

TABLE 50              PASSIVE: EXOSKELETON MARKET, BY MOBILITY, 2021–2024 (USD MILLION)     115

TABLE 51              PASSIVE: EXOSKELETON MARKET, BY MOBILITY, 2025–2030 (USD MILLION)     115

TABLE 52             PASSIVE: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION)            116

TABLE 53             PASSIVE: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION)            116

TABLE 54              EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION)       118

TABLE 55              EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION)       119

TABLE 56              HEALTHCARE: EXOSKELETON MARKET, BY TYPE, 2021–2024 (USD MILLION)                120

TABLE 57              HEALTHCARE: EXOSKELETON MARKET, BY TYPE, 2025–2030 (USD MILLION)                120

TABLE 58              HEALTHCARE: EXOSKELETON MARKET, BY REGION, 2021–2024 (USD MILLION)          120

TABLE 59              HEALTHCARE: EXOSKELETON MARKET, BY REGION, 2025–2030 (USD MILLION)          120

TABLE 60              HEALTHCARE: EXOSKELETON MARKET, FOR NORTH AMERICA,

BY COUNTRY, 2021–2024 (USD MILLION)               121

TABLE 61              HEALTHCARE: EXOSKELETON MARKET, FOR NORTH AMERICA,

BY COUNTRY, 2025–2030 (USD MILLION)               121

TABLE 62              HEALTHCARE: EXOSKELETON MARKET, FOR EUROPE, BY COUNTRY,

2021–2024 (USD MILLION)            121

TABLE 63              HEALTHCARE: EXOSKELETON MARKET, FOR EUROPE, BY COUNTRY,

2025–2030 (USD MILLION)            122

TABLE 64              HEALTHCARE: EXOSKELETON MARKET, FOR ASIA PACIFIC, BY COUNTRY,

2021–2024 (USD MILLION)            122

TABLE 65              HEALTHCARE: EXOSKELETON MARKET, FOR ASIA PACIFIC, BY COUNTRY,

2025–2030 (USD MILLION)            123

TABLE 66              HEALTHCARE: EXOSKELETON MARKET, FOR ROW, BY REGION,

2021–2024 (USD MILLION)            123

TABLE 67              HEALTHCARE: EXOSKELETON MARKET, FOR ROW, BY REGION,

2025–2030 (USD MILLION)            123

TABLE 68              DEFENSE: EXOSKELETON MARKET, BY TYPE, 2021–2024 (USD MILLION)            125

TABLE 69              DEFENSE: EXOSKELETON MARKET, BY TYPE, 2025–2030 (USD MILLION)            125

TABLE 70              DEFENSE: EXOSKELETON MARKET, BY REGION, 2021–2024 (USD MILLION)            126

TABLE 71              DEFENSE: EXOSKELETON MARKET, BY REGION, 2025–2030 (USD MILLION)            126

TABLE 72              DEFENSE: EXOSKELETON MARKET, FOR NORTH AMERICA, BY COUNTRY,

2021–2024 (USD MILLION)            126

TABLE 73              DEFENSE: EXOSKELETON MARKET, FOR NORTH AMERICA, BY COUNTRY,

2025–2030 (USD MILLION)            127

TABLE 74              DEFENSE: EXOSKELETON MARKET, FOR EUROPE, BY COUNTRY,

2021–2024 (USD MILLION)            127

TABLE 75              DEFENSE: EXOSKELETON MARKET, FOR EUROPE, BY COUNTRY,

2025–2030 (USD MILLION)            127

TABLE 76              DEFENSE: EXOSKELETON MARKET, FOR ASIA PACIFIC, BY COUNTRY,

2021–2024 (USD THOUSAND)      128

TABLE 77              DEFENSE: EXOSKELETON MARKET, FOR ASIA PACIFIC, BY COUNTRY,

2025–2030 (USD THOUSAND)      128

TABLE 78              DEFENSE: EXOSKELETON MARKET, FOR ROW, BY REGION,

2021–2024 (USD THOUSAND)      129

TABLE 79              DEFENSE: EXOSKELETON MARKET, FOR ROW, BY REGION,

2025–2030 (USD THOUSAND)      129

TABLE 80             INDUSTRIAL: EXOSKELETON MARKET, BY TYPE, 2021–2024 (USD MILLION)            130

TABLE 81             INDUSTRIAL: EXOSKELETON MARKET, BY TYPE, 2025–2030 (USD MILLION)            131

TABLE 82              INDUSTRIAL: EXOSKELETON MARKET, BY REGION, 2021–2024 (USD MILLION)          131

TABLE 83              INDUSTRIAL: EXOSKELETON MARKET, BY REGION, 2025–2030 (USD MILLION)          131

TABLE 84              INDUSTRIAL: EXOSKELETON MARKET, FOR NORTH AMERICA, BY COUNTRY,

2021–2024 (USD MILLION)            131

TABLE 85              INDUSTRIAL: EXOSKELETON MARKET, FOR NORTH AMERICA, BY COUNTRY,

2025–2030 (USD MILLION)            132

TABLE 86              INDUSTRIAL: EXOSKELETON MARKET, FOR EUROPE, BY COUNTRY,

2021–2024 (USD MILLION)            132

TABLE 87              INDUSTRIAL: EXOSKELETON MARKET, FOR EUROPE, BY COUNTRY,

2025–2030 (USD MILLION)            132

TABLE 88              INDUSTRIAL: EXOSKELETON MARKET, FOR ASIA PACIFIC, BY COUNTRY,

2021–2024 (USD MILLION)            133

TABLE 89              INDUSTRIAL: EXOSKELETON MARKET, FOR ASIA PACIFIC, BY COUNTRY,

2025–2030 (USD MILLION)            133

TABLE 90              INDUSTRIAL: EXOSKELETON MARKET, FOR ROW, BY REGION,

2021–2024 (USD MILLION)            134

TABLE 91              INDUSTRIAL: EXOSKELETON MARKET, FOR ROW, BY REGION,

2025–2030 (USD MILLION)            134

TABLE 92              CONSTRUCTION: EXOSKELETON MARKET, BY TYPE, 2021–2024 (USD MILLION)                136

TABLE 93              CONSTRUCTION: EXOSKELETON MARKET, BY TYPE, 2025–2030 (USD MILLION)                136

TABLE 94              CONSTRUCTION: EXOSKELETON MARKET, BY REGION, 2021–2024 (USD MILLION)          137

TABLE 95              CONSTRUCTION: EXOSKELETON MARKET, BY REGION, 2025–2030 (USD MILLION)          137

TABLE 96              CONSTRUCTION: EXOSKELETON MARKET, FOR NORTH AMERICA,

BY COUNTRY, 2021–2024 (USD MILLION)               137

TABLE 97              CONSTRUCTION: EXOSKELETON MARKET, FOR NORTH AMERICA,

BY COUNTRY, 2025–2030 (USD MILLION)               137

TABLE 98              CONSTRUCTION: EXOSKELETON MARKET, FOR EUROPE, BY COUNTRY,

2021–2024 (USD MILLION)            138

TABLE 99              CONSTRUCTION: EXOSKELETON MARKET, FOR EUROPE, BY COUNTRY,

2025–2030 (USD MILLION)            138

TABLE 100            CONSTRUCTION: EXOSKELETON MARKET, FOR ASIA PACIFIC, BY COUNTRY,

2021–2024 (USD MILLION)            139

TABLE 101            CONSTRUCTION: EXOSKELETON MARKET, FOR ASIA PACIFIC, BY COUNTRY,

2025–2030 (USD MILLION)            139

TABLE 102            CONSTRUCTION: EXOSKELETON MARKET, FOR ROW, BY REGION,

2021–2024 (USD THOUSAND)      140

TABLE 103            CONSTRUCTION: EXOSKELETON MARKET, FOR ROW, BY REGION,

2025–2030 (USD THOUSAND)      140

TABLE 104            OTHER VERTICALS: EXOSKELETON MARKET, BY TYPE, 2021–2024 (USD MILLION)         141

TABLE 105            OTHER VERTICALS: EXOSKELETON MARKET, BY TYPE, 2025–2030 (USD MILLION)         141

TABLE 106            OTHER VERTICALS: EXOSKELETON MARKET, BY REGION,

2021–2024 (USD MILLION)            142

TABLE 107            OTHER VERTICALS: EXOSKELETON MARKET, BY REGION,

2025–2030 (USD MILLION)            142

TABLE 108            OTHER VERTICALS: EXOSKELETON MARKET, FOR NORTH AMERICA,

BY COUNTRY, 2021–2024 (USD MILLION)               142

TABLE 109            OTHER VERTICALS: EXOSKELETON MARKET, FOR NORTH AMERICA, BY COUNTRY, 2025–2030 (USD MILLION)                 143

TABLE 110            OTHER VERTICALS: EXOSKELETON MARKET, FOR EUROPE, BY COUNTRY,

2021–2024 (USD MILLION)            143

TABLE 111            OTHER VERTICALS: EXOSKELETON MARKET, FOR EUROPE, BY COUNTRY,

2025–2030 (USD MILLION)            143

TABLE 112            OTHER VERTICALS: EXOSKELETON MARKET, FOR ASIA PACIFIC, BY COUNTRY, 2021–2024 (USD THOUSAND)                 144

TABLE 113            OTHER VERTICALS: EXOSKELETON MARKET, FOR ASIA PACIFIC, BY COUNTRY, 2025–2030 (USD THOUSAND)                 144

TABLE 114            OTHER VERTICALS: EXOSKELETON MARKET, FOR ROW, BY REGION,

2021–2024 (USD THOUSAND)      145

TABLE 115            OTHER VERTICALS: EXOSKELETON MARKET, FOR ROW, BY REGION,

2025–2030 (USD THOUSAND)      145

TABLE 116            EXOSKELETON MARKET, BY REGION, 2021–2024 (USD MILLION) 147

TABLE 117            EXOSKELETON MARKET, BY REGION, 2025–2030 (USD MILLION) 147

TABLE 118            NORTH AMERICA: EXOSKELETON MARKET, BY COUNTRY,

2021–2024 (USD MILLION)            150

TABLE 119            NORTH AMERICA: EXOSKELETON MARKET, BY COUNTRY,

2025–2030 (USD MILLION)            150

TABLE 120            US: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION)            151

TABLE 121            US: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION)            151

TABLE 122            CANADA: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION)     152

TABLE 123            CANADA: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION)     152

TABLE 124          MEXICO: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION)            153

TABLE 125          MEXICO: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION)            153

TABLE 126            EUROPE: EXOSKELETON MARKET, BY COUNTRY, 2021–2024 (USD MILLION)     155

TABLE 127            EUROPE: EXOSKELETON MARKET, BY COUNTRY, 2025–2030 (USD MILLION)     155

TABLE 128            UK: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION)            156

TABLE 129            UK: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION)            156

TABLE 130            GERMANY: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION)     157

TABLE 131            GERMANY: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION)     157

TABLE 132          FRANCE: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION)            158

TABLE 133          FRANCE: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION)            158

TABLE 134            ITALY: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION)            159

TABLE 135            ITALY: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION)            160

TABLE 136            POLAND: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION)     160

TABLE 137            POLAND: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION)     161

TABLE 138            NORDICS: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION)     161

TABLE 139            NORDICS: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION)     162

TABLE 140            REST OF EUROPE: EXOSKELETON MARKET, BY VERTICAL,

2021–2024 (USD MILLION)            162

TABLE 141            REST OF EUROPE: EXOSKELETON MARKET, BY VERTICAL,

2025–2030 (USD MILLION)            163

TABLE 142            ASIA PACIFIC: EXOSKELETON MARKET, BY COUNTRY, 2021–2024 (USD MILLION)     165

TABLE 143            ASIA PACIFIC: EXOSKELETON MARKET, BY COUNTRY, 2025–2030 (USD MILLION)     166

TABLE 144            CHINA: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION)            167

TABLE 145            CHINA: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION)            167

TABLE 146            JAPAN: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION)            168

TABLE 147            JAPAN: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION)            168

TABLE 148            SOUTH KOREA: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION)     169

TABLE 149            SOUTH KOREA: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION)     169

TABLE 150            INDIA: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION)            170

TABLE 151            INDIA: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION)            171

TABLE 152            AUSTRALIA: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION)     171

TABLE 153            AUSTRALIA: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION)     172

TABLE 154            INDONESIA: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD THOUSAND)                172

TABLE 155            INDONESIA: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD THOUSAND)                173

TABLE 156            MALAYSIA: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD THOUSAND)                173

TABLE 157            MALAYSIA: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD THOUSAND)                174

TABLE 158            THAILAND: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD THOUSAND)                174

TABLE 159            THAILAND: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD THOUSAND)                175

TABLE 160            VIETNAM: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD THOUSAND)                175

TABLE 161            VIETNAM: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD THOUSAND)                176

TABLE 162            REST OF ASIA PACIFIC: EXOSKELETON MARKET, BY VERTICAL,

2021–2024 (USD THOUSAND)      176

TABLE 163            REST OF ASIA PACIFIC: EXOSKELETON MARKET, BY VERTICAL,

2025–2030 (USD THOUSAND)      177

TABLE 164            ROW: EXOSKELETON MARKET, BY REGION, 2021–2024 (USD MILLION)            177

TABLE 165            ROW: EXOSKELETON MARKET, BY REGION, 2025–2030 (USD MILLION)            178

TABLE 166            MIDDLE EAST: EXOSKELETON MARKET, BY COUNTRY,

2021–2024 (USD THOUSAND)      178

TABLE 167            MIDDLE EAST: EXOSKELETON MARKET, BY COUNTRY,

2025–2030 (USD THOUSAND)      179

TABLE 168            MIDDLE EAST: EXOSKELETON MARKET, BY VERTICAL,

2021–2024 (USD THOUSAND)      179

TABLE 169            MIDDLE EAST: EXOSKELETON MARKET, BY VERTICAL,

2025–2030 (USD THOUSAND)      179

TABLE 170            SOUTH AMERICA: EXOSKELETON MARKET, BY VERTICAL,

2021–2024 (USD MILLION)            183

TABLE 171            SOUTH AMERICA: EXOSKELETON MARKET, BY VERTICAL,

2025–2030 (USD MILLION)            183

TABLE 172            AFRICA: EXOSKELETON MARKET, BY COUNTRY, 2021–2024 (USD THOUSAND)      184

TABLE 173            AFRICA: EXOSKELETON MARKET, BY COUNTRY, 2025–2030 (USD THOUSAND)      184

TABLE 174            AFRICA: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD THOUSAND)      184

TABLE 175            AFRICA: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD THOUSAND)      185

TABLE 176            OVERVIEW OF STRATEGIES ADOPTED BY MAJOR COMPANIES,

JANUARY 2022−FEBRUARY 2025                 186

TABLE 177            EXOSKELETON MARKET: DEGREE OF COMPETITION, 2024       189

TABLE 178            EXOSKELETON MARKET: REGION FOOTPRINT                 196

TABLE 179            EXOSKELETON MARKET: VERTICAL FOOTPRINT       197

TABLE 180            EXOSKELETON MARKET: TYPE FOOTPRINT                 198

TABLE 181            EXOSKELETON MARKET: BODY PART FOOTPRINT       199

TABLE 182            EXOSKELETON MARKET: DETAILED LIST OF KEY STARTUPS/SMES    202

TABLE 183            EXOSKELETON MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES          203

TABLE 184          EXOSKELETON MARKET: PRODUCT LAUNCHES, JANUARY 2022–FEBRUARY 2025  204

TABLE 185            EXOSKELETON MARKET: DEALS, JANUARY 2022– FEBRUARY 2025     205

TABLE 186            EXOSKELETON MARKET: EXPANSIONS, JANUARY 2022–FEBRUARY 2025  206

TABLE 187            EXOSKELETON MARKET: OTHER DEVELOPMENTS,

JANUARY 2022– FEBRUARY 2025 207

TABLE 188            EKSO BIONICS: COMPANY OVERVIEW   208

TABLE 189            EKSO BIONICS: PRODUCTS/SOLUTIONS/SERVICES OFFERED    209

TABLE 190            EKSO BIONICS: PRODUCT LAUNCHES   210

TABLE 191            EKSO BIONICS: DEALS   210

TABLE 192            EKSO BIONICS: OTHER DEVELOPMENTS                 211

TABLE 193            OTTOBOCK: COMPANY OVERVIEW        212

TABLE 194            OTTOBOCK: PRODUCTS/SOLUTIONS/SERVICES OFFERED    212

TABLE 195            OTTOBOCK: PRODUCT LAUNCHES         213

TABLE 196            DIH MEDICAL: COMPANY OVERVIEW    214

TABLE 197            DIH MEDICAL: PRODUCTS/SOLUTIONS/SERVICES OFFERED    215

TABLE 198            DIH MEDICAL: DEALS    216

TABLE 199            COMAU: COMPANY OVERVIEW 218

TABLE 200            COMAU: PRODUCTS/SOLUTIONS/SERVICES OFFERED             218

TABLE 201            COMAU: PRODUCT LAUNCHES 219

TABLE 202            MYOMO INC.: COMPANY OVERVIEW      221

TABLE 203            MYOMO INC..: PRODUCTS/SOLUTIONS/SERVICES OFFERED    222

TABLE 204            MYOMO INC.: PRODUCT LAUNCHES      222

TABLE 205            MYOMO INC.: OTHER DEVELOPMENTS 223

TABLE 206            CYBERDYNE INC.: COMPANY OVERVIEW                 224

TABLE 207            CYBERDYNE INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED    225

TABLE 208            CYBERDYNE INC.: EXPANSIONS 226

TABLE 209            LIFEWARD LTD.: COMPANY OVERVIEW 227

TABLE 210            LIFEWARD LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED    228

TABLE 211            LIFEWARD LTD: DEALS 229

TABLE 212            HYUNDAI MOTOR GROUP ROBOTICS LAB.: COMPANY OVERVIEW   230

TABLE 213            HYUNDAI MOTOR GROUP ROBOTICS LAB.: PRODUCTS/SOLUTIONS/SERVICES OFFERED    230

TABLE 214            HYUNDAI MOTOR GROUP ROBOTICS LAB.: PRODUCT LAUNCHES   231

TABLE 215            HYUNDAI MOTOR GROUP ROBOTICS LAB.: DEALS  231

TABLE 216            B-TEMIA: COMPANY OVERVIEW               232

TABLE 217            B-TEMIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED             232

TABLE 218            REX BIONICS LTD.: COMPANY OVERVIEW                 233

TABLE 219            REX BIONICS LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED    233

TABLE 220            ABLE HUMAN MOTION: COMPANY OVERVIEW                 234

TABLE 221            LAEVO EXOSKELETONS: COMPANY OVERVIEW                 235

TABLE 222            GERMAN BIONIC SYSTEMS GMBH: COMPANY OVERVIEW          236

TABLE 223            LEVITATE TECHNOLOGIES, INC.: COMPANY OVERVIEW          237

TABLE 224            FOURIER: COMPANY OVERVIEW               238

TABLE 225            TREXO ROBOTICS: COMPANY OVERVIEW                 239

TABLE 226            WANDERCRAFT: COMPANY OVERVIEW 240

TABLE 227            AGADE: COMPANY OVERVIEW  241

TABLE 228            EUROPE TECHNOLOGIES: COMPANY OVERVIEW          242

TABLE 229            GOGOA.EU: COMPANY OVERVIEW          243

TABLE 230            ARCHELIS INC.: COMPANY OVERVIEW  244

TABLE 231            P&S MECHANICS CO., LTD.: COMPANY OVERVIEW          245

TABLE 232            RB3D: COMPANY OVERVIEW      246

TABLE 233            JAPET MEDICAL DEVICES: COMPANY OVERVIEW          247

TABLE 234            PROTESO S.R.L.: COMPANY OVERVIEW 248

LIST OF FIGURES

FIGURE 1              EXOSKELETON MARKET: RESEARCH DESIGN                 29

FIGURE 2              MARKET SIZE ESTIMATION METHODOLOGY: SUPPLY-SIDE ANALYSIS                 35

FIGURE 3              MARKET SIZE ESTIMATION METHODOLOGY: APPROACH 2 (SUPPLY-SIDE)—IDENTIFICATION OF REVENUE GENERATED BY COMPANIES FROM SALES OF EXOSKELETON DEVICES              35

FIGURE 4              MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH              37

FIGURE 5              MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH                38

FIGURE 6              EXOSKELETON MARKET BREAKDOWN AND DATA TRIANGULATION                38

FIGURE 7              POWERED TYPE TO LEAD EXOSKELETON MARKET DURING FORECAST PERIOD    41

FIGURE 8              LOWER EXTREMITIES SEGMENT TO CAPTURE LARGEST MARKET SHARE THROUGHOUT FORECAST PERIOD                 41

FIGURE 9              HEALTHCARE VERTICAL TO LEAD EXOSKELETON MARKET DURING

FORECAST PERIOD         42

FIGURE 10            EUROPE TO ACCOUNT FOR LARGEST SHARE OF EXOSKELETON MARKET IN 2025                43

FIGURE 11            RISING DEMAND FOR PHYSICAL REHABILITATION AND MOBILITY SUPPORT SOLUTIONS TO DRIVE MARKET GROWTH            44

FIGURE 12            US AND HEALTHCARE VERTICAL TO HOLD LARGEST SHARE OF NORTH AMERICAN EXOSKELETON MARKET IN 2025                45

FIGURE 13            HEALTHCARE VERTICAL TO ACCOUNT FOR LARGEST SHARE OF EXOSKELETON MARKET IN ASIA PACIFIC THROUGHOUT FORECAST PERIOD        45

FIGURE 14            EXOSKELETON MARKET IN JAPAN TO GROW AT HIGHEST CAGR

FROM 2025 TO 2030          46

FIGURE 15            EXOSKELETON MARKET DYNAMICS: DRIVERS, RESTRAINTS, OPPORTUNITIES,

AND CHALLENGES          47

FIGURE 16            DRIVERS AND THEIR IMPACT ON EXOSKELETON MARKET               48

FIGURE 17            RESTRAINTS AND THEIR IMPACT ON EXOSKELETON MARKET               49

FIGURE 18            OPPORTUNITIES AND THEIR IMPACT ON EXOSKELETON MARKET               50

FIGURE 19            CHALLENGES AND THEIR IMPACT ON EXOSKELETON MARKET               51

FIGURE 20            EXOSKELETON MARKET: VALUE CHAIN ANALYSIS            53

FIGURE 21            EXOSKELETON MARKET: ECOSYSTEM ANALYSIS            54

FIGURE 22            EXOSKELETON MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS                 56

FIGURE 23            PRICING RANGE OF EXOSKELETON OFFERED BY KEY PLAYERS, BY TYPE, 2024 57

FIGURE 24            AVERAGE SELLING PRICE TREND OF EXOSKELETON, BY TYPE, 2022–2024 (USD)           58

FIGURE 25            AVERAGE SELLING PRICE TREND OF POWERED EXOSKELETON, BY REGION,

2022–2024 (USD)                59

FIGURE 26            AVERAGE SELLING PRICE TREND OF PASSIVE EXOSKELETON, BY REGION,

2022–2024 (USD)                60

FIGURE 27            PORTER’S FIVE FORCES ANALYSIS: EXOSKELETON MARKET               63

FIGURE 28            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR EXOSKELETONS

FOR TOP THREE VERTICALS       65

FIGURE 29            KEY BUYING CRITERIA FOR EXOSKELETONS FOR TOP THREE VERTICALS       66

FIGURE 30            FUNDS ACQUIRED BY COMPANIES IN EXOSKELETON 69

FIGURE 31            IMPORT DATA FOR HS CODE 9021-COMPLIANT PRODUCTS FOR TOP 5 COUNTRIES, 2020–2024   70

FIGURE 32            EXPORT DATA FOR HS CODE 9021-COMPLIANT PRODUCTS FOR TOP 5 COUNTRIES, 2020–2024   71

FIGURE 33            NUMBER OF PATENTS APPLIED AND GRANTED IN EXOSKELETON MARKET,

2014–2024              72

FIGURE 34            AI USE CASES     80

FIGURE 35            MOBILE SEGMENT TO HOLD LARGER SHARE OF EXOSKELETON MARKET IN 2030                93

FIGURE 36            LOWER EXTREMITIES BODY PART SEGMENT TO HOLD LARGEST SHARE OF EXOSKELETON MARKET IN 2030                 97

FIGURE 37            ACTUATORS TO HOLD LARGEST SHARE OF EXOSKELETON MARKET IN 2030                102

FIGURE 38            POWERED EXOSKELETONS TO HOLD LARGER SHARE OF EXOSKELETON

MARKET IN 2030                109

FIGURE 39            HEALTHCARE VERTICAL TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD 118

FIGURE 40            EXOSKELETON MARKET: REGIONAL SNAPSHOT                 147

FIGURE 41            NORTH AMERICA: EXOSKELETON MARKET SNAPSHOT          149

FIGURE 42            EUROPE: EXOSKELETON MARKET SNAPSHOT                 154

FIGURE 43            ASIA PACIFIC: EXOSKELETON MARKET SNAPSHOT          164

FIGURE 44            REVENUE ANALYSIS OF KEY PLAYERS IN EXOSKELETON MARKET, 2019–2023          188

FIGURE 45            MARKET SHARE ANALYSIS OF MAJOR PLAYERS, 2024        189

FIGURE 46            COMPANY VALUATION, 2024      191

FIGURE 47            FINANCIAL METRICS (EV/EBITDA), 2024                 191

FIGURE 48            EXOSKELETON MARKET: BRAND/PRODUCT COMPARISON   192

FIGURE 49            EXOSKELETON MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024         194

FIGURE 50            EXOSKELETON MARKET: COMPANY FOOTPRINT       195

FIGURE 51            EXOSKELETON MARKET: COMPANY EVALUATION MATRIX (SMES/STARTUPS), 2024 201

FIGURE 52            EKSO BIONICS: COMPANY SNAPSHOT   209

FIGURE 53            DIH MEDICAL: COMPANY SNAPSHOT    215

FIGURE 54            MYOMO INC.: COMPANY SNAPSHOT      222

FIGURE 55            CYBERDYNE INC.: COMPANY SNAPSHOT                 225

FIGURE 56            LIFEWARD LTD.: COMPANY SNAPSHOT                 228

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧